🧠 Cognitive Health & Neurodegenerative Disorders

​

Alzheimer's, Parkinson's, neurodegenerative disorders and age-related cognitive decline share a common thread: neuroinflammation, oxidative stress, and disrupted cellular communication. MSC-derived exosomes may cross the blood-brain barrier to deliver bioactive molecules targeting these mechanisms, including mitochondrial dysfunction, neuronal apoptosis, and chronic inflammation. Emerging research suggests potential neuroprotective and regenerative effects, though large-scale trials are ongoing.

🦴 Joint Pain & Osteoarthritis

​

Osteoarthritis and rheumatoid arthritis affect tens of millions and currently have no curative treatment. Intra-articular MSC injections have demonstrated meaningful pain relief and improved joint function in clinical studies. In one small pilot study of 33 Navy SEAL veterans, pain and disability scores improved significantly at 6 months post-infusion. A 2025 meta-analysis in Frontiers in Pharmacology confirmed multimodal benefits including cartilage protection, anti-inflammatory activity, and tissue regeneration.

​

​

🔴 Autoimmune and Neuromuscular Disorders

​

Mesenchymal stem cells (MSCs) are among the most extensively studied regenerative therapies for immune modulation and inflammation control. Early clinical research in autoimmune conditions such as lupus and neuromuscular disorders including ALS has demonstrated encouraging safety profiles and potential benefits in supporting immune balance, reducing inflammatory signaling, and improving quality of life.

​

​

​

​

🌸 Fertility & Ovarian Health

​

For women facing diminished ovarian reserve, premature ovarian insufficiency, or chemotherapy-related fertility challenges, MSC-derived exosomes are an active area of investigation. A 2024 systematic review confirmed improved follicle number and hormonal profiles in preclinical models, and a 2024 study in the American Journal of Obstetrics and Gynecology demonstrated potential protective effects on ovarian function following chemotherapy exposure.

💇 Hair Loss

​

MSC-derived exosomes are showing promise for hair loss such as male pattern baldness, chemotherapy-induced hair loss, and autoimmune hair disorders. A 2025 systematic review across 11 clinical studies found improvements in hair regeneration across all included research, with mechanisms involving reduced follicular inflammation and activation of key pathways governing the hair growth cycle. Our own patients note new hair growth within a month of treatment with our quadruple therapy formula of stem cells, exosomes, growth factors and cytokines that you won't find anywhere else.

🦴 Joint Pain & Osteoarthritis

​

Osteoarthritis and rheumatoid arthritis affect tens of millions and currently have no curative treatment. Intra-articular MSC injections have demonstrated meaningful pain relief and improved joint function in clinical studies. In one small pilot study of 33 Navy SEAL veterans, pain and disability scores improved significantly at 6 months post-infusion. A 2025 meta-analysis in Frontiers in Pharmacology confirmed multimodal benefits including cartilage protection, anti-inflammatory activity, and tissue regeneration.  Image shows repair of arthritic knee one year after a single injection of stem cells

​

​

⚡ Neuropathy

​

Peripheral neuropathy from diabetes, chemotherapy, or injury damages nerves outside the brain and spinal cord, causing chronic pain, weakness, and loss of sensation. MSC-derived exosomes contain proteins, microRNA, and messenger RNA that may support nerve regeneration and function. A 2024 review in Frontiers in Cellular Neuroscience documented neuroprotective effects across spinal cord injury, optic nerve damage, and peripheral nerve conditions.